Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 128 of 1,261
  1. US 11938233

    1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof

    UNIVERSITÄTSKLINIKUM REGENSBURG · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  2. US 11938182

    Halogenated xanthenes as vaccine adjuvants

    Provectus Pharmatech, Inc. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  3. US 11939301

    5HT1F receptor agonists and mitochondrial biogenesis

    United States Government as represented by the Department of Veterans Affairs · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  4. US 11939596

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  5. US 11938089

    Medication delivery systems and methods

    Amphastar Pharmaceuticals, Inc. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  6. US 11938150

    Treatment of neurodegenerative disease with sodium chlorite

    The Regents of the University of California · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  7. US 11939327

    Heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  8. US 11939317

    Amide compounds and method for making and using

    Rigel Pharmaceuticals, Inc. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  9. US 11939346

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    Compass Pathfinder Limited · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  10. US 11939343

    Sting agonist compounds and methods of use

    Mersana Therapeutics, Inc. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  11. US 11939392

    CD123 binding proteins and related compositions and methods

    Aptevo Research and Development LLC · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  12. US 11939581

    Methods and compositions for targeting PD-L1

    Aligos Therapeutics, Inc. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  13. US 11939402

    Antifungal peptides, compounds including the same, and methods of use thereof

    Seton Hall University · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  14. US 11939383

    B7-H4 antibodies and methods and use thereof

    Five Prime Therapeutics, Inc. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  15. US 11939379

    Antibody chemically induced dimerizer (AbCID) as molecular switches for regulating cellular therapies

    The Regents of the University of California · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  16. US 11939368

    QTY Fc fusion receptor proteins

    Avalon GloboCare Corp. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  17. US 11939363

    Translatable molecules and synthesis thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  18. US 11939591

    Genetically modified MSC and therapeutic methods

    The Regents of the University of California · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  19. US 11939365

    T cell receptors recognizing mutated P53

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  20. US 11939345

    Physiologically stable fluorophore and performing fluorescence probing

    Government of the United States of America, as represented by the Secretary of Commerce · Granted Mar 26, 2024 · Expires Mar 21, 2044

    granted
  21. US 11931343

    CD73 inhibitors

    Arcus Biosciences, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  22. US 11931375

    Treatment of amyotrophic lateral sclerosis (ALS)

    VOYAGER THERAPEUTICS, INC. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  23. US 11931340

    Use of sublingual dexmedetomidine for the treatment of agitation

    BioXcel Therapeutics, Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted
  24. US 11931338

    Nitrilated psilocybin derivatives and methods of using

    Enveric Biosciences Canada Inc. · Granted Mar 19, 2024 · Expires Mar 14, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.